The analysis of Global Hospital Discharges for Malignant Neoplasm of the Uterus in 2023 shows Mexico leading with 12.03 thousand discharges, followed by Chile with 3.8 thousand. Other countries like Belgium, Latvia, and Finland report values around 2 thousand, while Ireland shows the lowest at 0.916 thousand. Comparing year-on-year variations, Mexico and Latvia experienced minimal declines, whereas Finland and Chile noted higher drops indicating regional disparities. Over a five-year period, these countries have shown moderate to declining CAGR, reflecting a possible improvement in treatment efficacy or preventive measures.
Future trends to watch include:
- Increased focus on early detection and treatment advancements could further reduce hospital discharges.
- Investment in healthcare infrastructure in developing regions could impact discharge numbers.
- Monitoring demographic shifts and healthcare policies will be crucial for understanding future discharge trends globally.
Top countries in Hospital Discharges for Malignant Neoplasm of Uterus by Country
| # | 6 Countries | Units (Hospital Discharges) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Mexico | 12,030 | 2023 | +4.56% | -0.37% | View data |
| 2 | 2 Chile | 3,800 | 2023 | +3.09% | -1.85% | View data |
| 3 | 3 Belgium | 2,370 | 2023 | -1.09% | -1.67% | View data |
| 4 | 4 Latvia | 1,650 | 2023 | +2.94% | -0.34% | View data |
| 5 | 5 Finland | 1,620 | 2023 | -2.59% | -2.44% | View data |
| 6 | 6 Ireland | 916 | 2023 | +5.77% | -1.16% | View data |
